ENT Surgical Energy Device Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Capital Equipment and Radiofrequency (RF) and Ultrasonic Probes

ENT Surgical Energy Device Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Capital Equipment and Radiofrequency (RF) and Ultrasonic Probes

The global market for ENT surgical energy devices had a valuation of $479.3 million in 2022. It is projected to grow at a CAGR of 1.9% during the forecast period and reach $545.8 million. The comprehensive report covers capital equipment, as well as radiofrequency (RF) and ultrasonic probes used in ENT surgery.

MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL ENT SURGICAL ENERGY DEVICE MARKET INSIGHTS

The primary factor driving the ENT surgical energy device market is the level of precision these devices provide during ENT procedures. The probes create highly accurate lines of demarcation, which has led many physicians to prefer using these devices during operations on their patients.

GLOBAL ENT SURGICAL ENERGY DEVICE MARKET SHARE INSIGHTS

The Global ENT surgical energy device market was led by Smith & Nephew, Olympus, and Ethicon.
Smith & Nephew was the leading company in the ENT surgical energy device market in 2022, as it was the only major player in the market that did not offer both RF and ultrasonic energy-based devices. Its flagship product line, Coblation™, utilizes bipolar RF energy with the aid of a conductive medium. The company typically provides its generator for free when customers purchase probes, which allows it to generate most of its revenue and market share in the RF and ultrasonic probe segment.

MARKET SEGMENTATION SUMMARY

ENT Surgical Energy Device Market – MedCore – Includes:
Capital Equipment, Radiofrequency (RF) and Ultrasonic Probes.

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.